article thumbnail

Indivi to Collaborate with Biogen to Advance Digital Health Technology and Digital Biomarkers for Parkinson’s Disease

Digital Health Global

BASEL, Switzerland–(BUSINESS WIRE)–Indivi, a leading MedTech company headquartered in Basel, Switzerland, has entered into an agreement with Biogen to advance digital health technology and develop digital biomarkers for Parkinson’s disease.

article thumbnail

The Committee to Restore Nymox Shareholder Value Sends Letter to Nymox Pharmaceutical Shareholders and Issues Proxy Materials for Upcoming Special Meeting

Digital Health Global

CRNSV”) was formed by former executives and directors of Nymox Pharmaceutical Corporation (“Nymox” or the “Company”), who were improperly removed from their positions, with a goal to recover shareholder value in Nymox. & LONDON–(BUSINESS WIRE)– The Committee to Restore Nymox Shareholder Value, Inc.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

An interview with banker in disguise Dominick Kennerson, Senior VP for HealthTech at HSBC Innovation Banking

Digital Health Global

We bring a wealth of experience and expertise to the table, and thanks to our position as part of HSBC, we remain committed to supporting innovation and driving growth in sectors that are shaping our future, including health technology (HealthTech), around the world.

article thumbnail

MedaSystems Secures Additional Funding from Debiopharm Innovation Fund to Accelerate Global Access to Pre-approval Treatment

Digital Health Global

Our mutual dedication to building new approaches to pharmaceutical drug development and patient care will help bring promising pre-approval medicine to patients around the world, faster and more equitably. Since 2017, Debiopharm has invested in 15 AI and digital health companies, typically leading the investment rounds.

article thumbnail

Average Multiples and Key Drivers of Digital Therapeutics (DTx) M&A deals in 2023

Lloyd Price

Here are some additional insights into DTx M&A deals in 2023: The most active acquirers in the DTx M&A market are pharmaceutical companies, followed by technology companies. The most active subsectors for DTx M&A deals are mental health, oncology, and diabetes.

article thumbnail

Healthy Together Acquires Kinsa Health to Build AI Illness Forecasting & Expand into New Markets

Healthcare IT Today

Kinsa’s innovative approach to early warning and predictive analytics complements Healthy Together’s commitment to leverage technology for the greater good. This acquisition reinforces Healthy Together’s commitment to driving positive change in public health outcomes.

article thumbnail

Drug Discovery and Early Development Outsourcing Services Industry Analysis – M&As, Partnerships and the Shift Toward an End-to-end CRDMO Model will Boost Sector Expansion – ResearchAndMarkets.com

Digital Health Global

The global pharmaceutical research and development (R&D) pipeline accounts for more than 21,000 molecules, as of April 2023, indicating a 5.8% hike over 2022, with more than 6,100 molecules in active development. Moreover, advancements in multiple emerging biotechnology platforms (e.g.,